Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population
PurposeTo describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VEGF) agents.MethodsThis is a prospective cohort of...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
Frontiers Media S.A.
2024-01-01
|
Serija: | Frontiers in Ophthalmology |
Teme: | |
Online dostop: | https://www.frontiersin.org/articles/10.3389/fopht.2023.1346322/full |